GW Pharmaceuticals EV/EBIT
What is the EV/EBIT of GW Pharmaceuticals?
The EV/EBIT of GW Pharmaceuticals is N/A
What is the definition of EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT of companies in the Health Care sector on NASDAQ compared to GW Pharmaceuticals
Companies with ev/ebit similar to GW Pharmaceuticals
- Alberton Acquisition has EV/EBIT of N/A
- Sigma Lithium Resources has EV/EBIT of N/A
- Berkshire Hathaway has EV/EBIT of N/A
- Mukand has EV/EBIT of N/A
- Prajay Engineers Syndicate has EV/EBIT of N/A
- Everest Consolidator Acquisition has EV/EBIT of N/A
- GW Pharmaceuticals has EV/EBIT of N/A
- 88 has EV/EBIT of N/A
- Confederation Minerals has EV/EBIT of N/A
- MongoDB Inc has EV/EBIT of N/A
- Development has EV/EBIT of N/A
- Oi S.A has EV/EBIT of N/A
- American Superconductor has EV/EBIT of N/A